Reno-protective effect of fenofibrate and febuxostat against vancomycin-induced acute renal injury in rats: Targeting PPARγ/NF-κB/COX-II and AMPK/Nrf2/HO-1 signaling pathways

References

• Ingram PR, Lye DC, Tambyah PA, et al. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. J Antimicrob Chemother. 2008;62(1):168–171. doi: 10.1093/jac/dkn080.
   PubMed Web of Science ®Google Scholar
• Nishino Y, Takemura S, Minamiyama Y, et al. Inhibition of vancomycin-induced nephrotoxicityby targeting superoxide dismutase to renal proximal tubule cells in the rat. Redox Rep. 2002;7(5):317–319. doi: 10.1179/135100002125000884.
   PubMed Web of Science ®Google Scholar
• MoelleringJr.RC. Vancomycin: a 50-year reassessment. Clin Infect Dis. 2006;42 Suppl 1(Supplement_1):S3–S4. doi: 10.1086/491708.
   PubMedGoogle Scholar
• Elyasi S, Khalili H, Dashti-Khavidaki S, et al. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations: a literature review. Eur J Clin Pharmacol. 2012;68(9):1243–1255. doi: 10.1007/s00228-012-1259-9.
   PubMed Web of Science ®Google Scholar
• Lodise TP, Lomaestro B, Graves J, et al. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008;52(4):1330–1336. doi: 10.1128/AAC.01602-07.
   PubMed Web of Science ®Google Scholar
• Elting LS, Rubenstein EB, Kurtin D, et al. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice. Cancer. 1998;83(12):2597–2607. doi: 10.1002/(SICI)1097-0142(19981215)83:12<2597::AID-CNCR27>3.0.CO;2-L.
   PubMed Web of Science ®Google Scholar
• Bayomy NA, Abdelaziz EZ, Said MA, et al. Effect of pycnogenol and spirulina on vancomycin induced renal cortical oxidative stress, apoptosis and autophagy in adult male albino rat. Can J Physiol Pharmacol. 2016;94:1–40.
   PubMed Web of Science ®Google Scholar
• Arimura Y, Yano T, Hirano M, et al. Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis. Free Radic Biol Med. 2012;52(9):1865–1873. doi: 10.1016/j.freeradbiomed.2012.02.038.
   PubMed Web of Science ®Google Scholar
• Nishino Y, Takemura S, Minamiyama Y, et al. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radic Res. 2003;37(4):373–379. doi: 10.1080/1071576031000061002.
   PubMed Web of Science ®Google Scholar
• Oktem F, Arslan MK, Ozguner F, et al. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology. 2005;215(3):227–233. doi: 10.1016/j.tox.2005.07.009.
   PubMed Web of Science ®Google Scholar
• Hodoshima N, Nakano Y, Izumi M, et al. Protective effect of inactive ingredients against nephrotoxicity of vancomycin hydrochloride in rats. Drug Metab Pharmacokinet. 2004;19(1):68–75. doi: 10.2133/dmpk.19.68.
   PubMedGoogle Scholar
• Celik I, Cihangiroglu N, Ilhan N, et al. Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity. Basic Clin Pharmacol Toxicol. 2005;97(5):325–332. doi: 10.1111/j.1742-7843.2005.pto_153.x.
   PubMed Web of Science ®Google Scholar
• Abraham NG, Asija A, Drummond G, et al. Heme oxygenase -1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther. 2007;7(2):89–108. doi: 10.2174/156652307780363134.
   PubMed Web of Science ®Google Scholar
• Dieterich C, Puey A, Lin S, et al. Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates. Toxicol Sci. 2009;107(1):258–269. doi: 10.1093/toxsci/kfn203.
   PubMed Web of Science ®Google Scholar
• Fanos V, Cataldi L. Renal transport of antibiotics and nephrotoxicity: a review. J Chemother. 2001;13(5):461–472. doi: 10.1179/joc.2001.13.5.461.
   PubMed Web of Science ®Google Scholar
• Sánchez-Lozada LG, Tapia E, Soto V, et al. Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia. Nephron Physiol. 2008;108(4):p69–p78. doi: 10.1159/000127837.
   PubMedGoogle Scholar
• Tsuda H, Kawada N, Kaimori J, et al. Febuxostat suppressed renal ischemia–reperfusion injury via reduced oxidative stress. Biochem Biophys Res Commun. 2012;427(2):266–272. doi: 10.1016/j.bbrc.2012.09.032.
   PubMed Web of Science ®Google Scholar
• Sabán-Ruiz J, Alonso-Pacho A, Fabregate-Fuente M, et al. Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation. Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):94–99. doi: 10.2174/1871523011312010011.
   PubMedGoogle Scholar
• Omori H, Kawada N, Inoue K, et al. Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy. Clin Exp Nephrol. 2012;16(4):549–556. doi: 10.1007/s10157-012-0609-3.
   PubMed Web of Science ®Google Scholar
• Qu S, Dai C, Lang F, et al. Rutin attenuates vancomycin-induced nephrotoxicity by ameliorating oxidative stress, apoptosis, and inflammation in rats. Antimicrob Agents Chemother. 2018;63(1):e01545–18. doi: 10.1128/AAC.01545-18.
   PubMed Web of Science ®Google Scholar
• Sedik AA, Hassan AS, Shafey HI, et al. Febuxostat attenuates aluminum chloride-induced hepatorenal injury in rats with the impact of Nrf2, Crat, Car3, and MNK-mediated apoptosis. Environ Sci Pollut Res Int. 2023;30(35):83356–83375. doi: 10.1007/s11356-023-28182-9.
   PubMed Web of Science ®Google Scholar
• Ali AA, Saad EB, El-Rhman RHA, et al. Impact of peroxisome proliferator-activated receptor agonist drugs in a model of nephrotoxicity in rats. J Biochem Mol Toxicol. 2023;37:e23350.
   PubMed Web of Science ®Google Scholar
• Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271–278. doi: 10.1016/0003-2697(78)90342-1.
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25(1):192–205. doi: 10.1016/0003-2697(68)90092-4.
   PubMed Web of Science ®Google Scholar
• Marklund SL. Product of extracellular-superoxide dismutase catalysis. FEBS Lett. 1985;184(2):237–239. doi: 10.1016/0014-5793(85)80613-x.
   PubMed Web of Science ®Google Scholar
• Tousson E, Hafez E, Masoud A. Abrogation by curcumin on testicular toxicity induced by cisplatin in rats. J Cancer Res Treat. 2014;2:64–68.
   Google Scholar
• Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5(1):62–71. doi: 10.1006/niox.2000.0319.
   PubMed Web of Science ®Google Scholar
• Manktelow A, Meyer A. Lack of correlation between decreased chemotaxis and susceptibility to infection in burned rats. J Trauma. 1986;26(2):143–148. doi: 10.1097/00005373-198602000-00008.
   PubMedGoogle Scholar
• Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960;39(7):1157–1175. doi: 10.1172/JCI104130.
   PubMed Web of Science ®Google Scholar
• Van Weemen BK, Schuurs AHWM. Immunoassay using antigen-enzyme conjugates. FEBS Lett. 1971;15(3):232–236. doi: 10.1016/0014-5793(71)80319-8.
   PubMed Web of Science ®Google Scholar
• Wang SF, Abouzied MM, Smith DM. Protein as potential endpoint temperature indicators for ground beef patties. J Food Sci. 1996;61(1):5–7. doi: 10.1111/j.1365-2621.1996.tb14713.x.
   Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350.
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Gamble M. Theory and practice of histological techniques. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2013; pp. 172–186.
   Google Scholar
• Basarslan F, Yilmaz N, Ates S, et al. Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats. Hum Exp Toxicol. 2012;31(7):726–733. doi: 10.1177/0960327111433185.
   PubMed Web of Science ®Google Scholar
• Toyoguchi T, Takahashi S, Hosoya J, et al. Nephrotoxicity of vancomycin and drug interaction study with cilastatin in Rabbits. Antimicrob Agents Chemother. 1997;41(9):1985–1990. doi: 10.1128/AAC.41.9.1985.
   PubMed Web of Science ®Google Scholar
• Khalaf MM, Hassan SM, Sayed AM, et al. Ameliorate impacts of scopoletin against vancomycin-induced intoxication in rat model through modulation of Keap1-Nrf2/HO-1 and IκBα-P65 NF-κB/P38 MAPK signaling pathways: molecular study, molecular docking evidence and network pharmacology analysis. Int Immunopharmacol. 2022;102:108382. doi: 10.1016/j.intimp.2021.108382.
   PubMed Web of Science ®Google Scholar
• Fouad AA, Albuali WH, Zahran A, et al. Protective effect of naringenin against gentami- cin-induced nephrotoxicity in rats. Environ Toxicol Pharmacol. 2014;38(2):420–429. doi: 10.1016/j.etap.2014.07.015.
   PubMed Web of Science ®Google Scholar
• Dalaklioglu S, Tekcan M, Gungor NE, et al. Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury. Toxicol Lett. 2010;192(2):91–96. doi: 10.1016/j.toxlet.2009.10.002.
   PubMed Web of Science ®Google Scholar
• Kim HS, Lim SW, Jin L, et al. The protective effect of febuxostat on chronic tacrolimus-induced nephrotoxicity in rats. Nephron. 2017;135(1):61–71. doi: 10.1159/000449289.
   PubMed Web of Science ®Google Scholar
• Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol. 2001;12(12):2683–2690. doi: 10.1681/ASN.V12122683.
   PubMed Web of Science ®Google Scholar
• Ahmida MHS. Protective role of curcumin in nephrotoxic oxidative damage induced by vancomycin in rats. Exp Toxicol Pathol. 2012;64(3):149–153. doi: 10.1016/j.etp.2010.07.010.
   PubMedGoogle Scholar
• Gupta A, Biyani M, Khaira A. Vancomycin nephrotoxicity: myths and facts. Neth J Med. 2011;69(9):379–383.
   PubMed Web of Science ®Google Scholar
• Khaliq H, Jing W, Ke X, et al. Boron affects the development of the kidney through modulation of apoptosis, antioxidant capacity, and Nrf2 pathway in the African Ostrich chicks. Biol Trace Elem Res. 2018;186(1):226–237. doi: 10.1007/s12011-018-1280-7.
   PubMed Web of Science ®Google Scholar
• Kerasioti E, Stagos D, Tzimi A, et al. Increase in antioxidant activity by sheep/goat whey protein through nuclear factor-like 2 (Nrf2) is cell type dependent. Food Chem Toxicol. 2016;97:47–56. doi: 10.1016/j.fct.2016.08.022.
   PubMed Web of Science ®Google Scholar
• Cantaluppi V, Quercia AD, Dellepiane S, et al. Interaction between systemic inflammation and renal tubular epithelial cells. Nephrol Dial Transplant. 2014;29(11):2004–2011. doi: 10.1093/ndt/gfu046.
   PubMed Web of Science ®Google Scholar
• Tagde P, Tagde P, Islam F, et al. The multifaceted role of curcumin in advanced nanocurcumin form in the treatment and management of chronic disorders. Molecules. 2021;26(23):7109. doi: 10.3390/molecules26237109.
   PubMed Web of Science ®Google Scholar
• Kabir MT, Rahman MH, Akter R, et al. Potential role of curcumin and its nanoformulations to treat various types of cancers. Biomolecules. 2021;11(3):392. doi: 10.3390/biom11030392.
   PubMed Web of Science ®Google Scholar
• Liu G, Qu J, Shen X. NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta. 2008;1783(5):713–727. doi: 10.1016/j.bbamcr.2008.01.002.
   PubMed Web of Science ®Google Scholar
• Gao W, Guo L, Yang Y, et al. Dissecting the crosstalk between Nrf2 and NF-κB response pathways in drug-induced toxicity. Front Cell Dev Biol. 2022;9:1–21. doi: 10.3389/fcell.2021.809952.
   Web of Science ®Google Scholar
• Khalaf MM, Hassan SM, Sayed AM, et al. Carvacrol mitigates vancomycin-induced nephrotoxicity via regulation of IkBα/p38MAPK and Keap1/Nrf2 signaling pathways: an experimental study with in silico evidence. Eur Rev Med Pharmacol Sci. 2022;26(23):8738–8755. doi: 10.26355/eurrev_202212_30546.
   PubMed Web of Science ®Google Scholar
• Xu W, Mao Z, Zhao B, et al. Vitamin C attenuates vancomycin induced nephrotoxicity through the reduction of oxidative stress and inflammation in HK-2 cells. Ann Palliat Med. 2021;10(2):1748–1754. doi: 10.21037/apm-20-694.
   PubMed Web of Science ®Google Scholar
• Khames A, Khalaf MM, Gad AM, et al. Ameliorative effects of sildenafil and/or febuxostat on doxorubicin-induced nephrotoxicity in rats. Eur J Pharmacol. 2017;805:118–124. doi: 10.1016/j.ejphar.2017.02.046.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen F, Deng L, et al. Febuxostat attenuates paroxysmal atrial fibrillation-induced regional endothelial dysfunction. Thromb Res. 2017;149:17–24. doi: 10.1016/j.thromres.2016.11.011.
   PubMed Web of Science ®Google Scholar
• Nomura J, Busso N, Ives A, et al. Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice. Sci Rep. 2014;4(1):4554. doi: 10.1038/srep04554.
   PubMedGoogle Scholar
• Mizuno Y, Yamamotoya T, Nakatsu Y, et al. Xanthine oxidase inhibitor febuxostat exerts an anti-inflammatory action and protects against diabetic nephropathy development in KK-Ay obese diabetic mice. IJMS. 2019;20(19):4680. doi: 10.3390/ijms20194680.
   Google Scholar
• Komers R, Xu B, Schneider J, et al. Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes. Br J Pharmacol. 2016;173(17):2573–2588. doi: 10.1111/bph.13527.
   PubMed Web of Science ®Google Scholar
• He L, Fan Y, Xiao W, et al. Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy. Oncotarget. 2017;8(67):111295–111308. doi: 10.18632/oncotarget.22784.
   PubMedGoogle Scholar
• Ran J, Xu G, Ma H, et al. Febuxostat attenuates renal damage besides exerting hypouricemic effect in streptozotocin-induced diabetic rats. Int J Nephrol. 2017;2017:2739539. doi: 10.1155/2017/2739539.
   PubMed Web of Science ®Google Scholar
• Helmy MM, Helmy MW, El-Mas MM. Additive renoprotection by pioglitazone and fenofibrate against inflammatory, oxidative and apoptotic manifestations of cisplatin nephrotoxicity: modulation by PPARs. PLoS One. 2015;10(11):e0142303. doi: 10.1371/journal.pone.0142303.
   PubMed Web of Science ®Google Scholar
• Ratner RE, Parikh S, Tou C. Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes. Diab Vasc Dis Res. 2007;4(3):214–221. doi: 10.3132/dvdr.2007.042.
   PubMedGoogle Scholar
• Elsisi AEE, Sokar SS, Shalaby MF, et al. Nephroprotective effects of febuxostat and/or mirtazapine against gentamicin-induced nephrotoxicity through modulation of ERK 1/2, NF-κB and MCP1, Expert. Expert Rev Clin Pharmacol. 2021;14(8):1039–1050. doi: 10.1080/17512433.2021.1933435.
   PubMed Web of Science ®Google Scholar
• Omizo H, Tamura Y, Morimoto C, et al. Cardio-renal protective effect of the xanthine oxidase inhibitor febuxostat in the 5/6 nephrectomy model with hyperuricemia. Sci Rep. 2020;10(1):9326. doi: 10.1038/s41598-020-65706-6.
   PubMed Web of Science ®Google Scholar
• Yang K, Choi WJ, Chang Y, et al. Inhibition of xanthine oxidase protects against diabetic kidney disease through the amelioration of oxidative stress via VEGF/VEGFR Axis and NOX-FoxO3a-eNOS signaling pathway. IJMS. 2023;24(4):3807. doi: 10.3390/ijms24043807.
   Google Scholar
• Yaribeygi H, Mohammadi MT, Rezaee R, et al. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy. J Cell Biochem. 2018;119(9):7458–7469. doi: 10.1002/jcb.27055.
   PubMed Web of Science ®Google Scholar
• Ibrahim MA, El-Sheikh AAK, Khalaf HM, et al. Protective effect of peroxisome proliferator activator receptor (PPAR)-α and -γ ligands against methotrexate-induced nephrotoxicity. Immunopharmacol Immunotoxicol. 2014;36(2):130–137. doi: 10.3109/08923973.2014.884135.
   PubMed Web of Science ®Google Scholar
• Park C, Ji H, Kim S, et al. Fenofibrate exerts protective effects against gentamicin-induced toxicity in cochlear hair cells by activating antioxidant enzymes. Int J Mol Med. 2017;39(4):960–968. doi: 10.3892/ijmm.2017.2916.
   PubMed Web of Science ®Google Scholar
• Alqahtani MJ, Negm WA, Saad HM, et al. Fenofibrate and Diosmetin in a rat model of testicular toxicity: new insight on their protective mechanism through PPAR-α/NRF-2/HO-1 signaling pathway. Biomed Pharmacother. 2023;165:115095. doi: 10.1016/j.biopha.2023.115095.
   PubMed Web of Science ®Google Scholar
• Yu P, Luo J, Song H, et al. N-acetylcysteine Ameliorates Vancomycin-induced nephrotoxicity by inhibiting oxidative stress and apoptosis in the in vivo and in vitro models. Int J Med Sci. 2022;19(4):740–752. doi: 10.7150/ijms.69807.
   PubMed Web of Science ®Google Scholar
• Pang H, Qin X, Liu T, et al. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: a prospective study. Eur Rev Med Pharmacol Sci. 2017;21(18):4203–4213.
   PubMed Web of Science ®Google Scholar
• Pais GM, Avedissian SN, O’Donnell JN, et al. Comparative performance of urinary biomarkers for vancomycin-induced kidney injury according to timeline of injury. Antimicrob. Agents Chemother. 2019;63:e00079–19.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab BA, El-Shoura EAM, Shafiuddin Habeeb M, et al. Febuxostat alleviates arsenic trioxide-induced renal injury in rats: insights on the crosstalk between NLRP3/TLR4, Sirt-1/NF-κB/TGF-β signaling Pathways, and miR-23b-3p, miR-181a-5b expression. Biochem Pharmacol. 2023;216:115794. doi: 10.1016/j.bcp.2023.115794.
   Google Scholar
• Ovcharenko E, Hansen MK, Goltsman I, et al. Peroxisome proliferator-activated receptor alpha and Alpha/Gamma agonists do not cause impairment in renal function in the rat. Nephron Physiol. 2010;115(3):p21–30. doi: 10.1159/000314541.
   PubMedGoogle Scholar
• Gharishvandi F, Kazerouni F, Ghanei E, et al. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and Cystatin C as early biomarkers for early detection of renal failure in patients with hypertension. Iran Biomed. J. 2015;19:76–81.
   PubMedGoogle Scholar
• Sezai A, Soma M, Nakata K, et al. Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients (NU-FLASH Trial. Circ J. 2013;77(8):2043–2049. doi: 10.1253/circj.cj-13-0082.
   PubMed Web of Science ®Google Scholar
• Ncube V, Starkey B, Wang T. Effect of fenofibrate treatment for hyperlipidaemia on serum creatinine and cystatin C. Ann Clin Biochem. 2012;49(Pt 5):491–493. doi: 10.1258/acb.2012.011163.
   PubMedGoogle Scholar
• Ma Y, Shi M, Wang Y, et al. PPARγ and its agonists in chronic kidney disease. Int J Nephrol. 2020;2020:2917474. doi: 10.1155/2020/2917474.
   PubMed Web of Science ®Google Scholar
• Corrales P, Izquierdo-Lahuerta A, Medina-Gómez G. Maintenance of kidney metabolic homeostasis by PPAR gamma. IJMS. 2018;19(7):2063. doi: 10.3390/ijms19072063.
   Google Scholar
• Emeka P, Rasool S, Morsy M, et al. Protective effects of lutein against vancomycin-induced acute renal injury in mice via upregulation of peroxisome proliferator-activated receptor gamma/nuclear factor erythroid 2-related factor 2 and inhibition nuclear factor-kappaB/caspase 3. Korean J Physiol Pharmacol. 2021;25(4):321–331. doi: 10.4196/kjpp.2021.25.4.321.
   PubMed Web of Science ®Google Scholar
• Diep QN, Schiffrin EL. Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats. Hypertension. 2001;38(2):249–254. doi: 10.1161/01.hyp.38.2.249.
   PubMed Web of Science ®Google Scholar
• Zhang B, Lo C, Shen L, et al. The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood. 2011;117(17):4569–4579. doi: 10.1182/blood-2010-09-304931.
   PubMed Web of Science ®Google Scholar
• Humanes B, Jado JC, Camaño S, et al. Protective effects of cilastatin against vancomycin-induced nephrotoxicity. Biomed Res Int. 2015;2015:704382. doi: 10.1155/2015/704382.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Jin H, Huo X, et al. Protective effect of Rhein against vancomycin-induced nephrotoxicity through regulating renal transporters and Nrf2 pathway. Phytother Res. 2022;36(11):4244–4262. doi: 10.1002/ptr.7559.
   PubMed Web of Science ®Google Scholar
• Im DS, Shin HJ, Yang KJ, et al. Cilastatin attenuates vancomycin-induced nephrotoxicity via P-glycoprotein. Toxicol Lett. 2017;277:9–17. doi: 10.1016/j.toxlet.2017.05.023.
   PubMed Web of Science ®Google Scholar
• Khan SI, Malhotra RK, Rani N, et al. Febuxostat modulates MAPK/NF- κ Bp65/TNF- α signaling in cardiac ischemia-reperfusion injury. Oxid Med Cell Longev. 2017;2017:8095825. doi: 10.1155/2017/8095825.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy B, Rani N, Bharti S, et al. Febuxostat ameliorates doxorubicin-induced cardiotoxicity in rats. Chem Biol Interact. 2015;237:96–103. doi: 10.1016/j.cbi.2015.05.013.
   PubMed Web of Science ®Google Scholar
• Kortam MA, Alawady AS, Sadik NA, et al. Fenofibrate mitigates testosterone induced benign prostatic hyperplasia via regulation of Akt/FOXO3a pathway and modulation of apoptosis and proliferation in rats. Arch Biochem Biophys. 2022;723:109237. doi: 10.1016/j.abb.2022.109237.
   PubMed Web of Science ®Google Scholar
• Guzel S, Sahinogullari ZU, Canacankatan N, et al. Potential renoprotective effects of silymarin against vancomycin-induced nephrotoxicity in rats. Drug Chem Toxicol. 2020;43(6):630–636. doi: 10.1080/01480545.2019.1584208.
   PubMed Web of Science ®Google Scholar
• Ibrahim YF, Fadl RR, Ibrahim S, et al. Protective effect of febuxostat in sepsis-induced liver and kidney injuries after cecal ligation and puncture with the impact of xanthine oxidase, interleukin 1 β, and c-Jun N-terminal kinases. Hum Exp Toxicol. 2020;39(7):906–919. doi: 10.1177/0960327120905957.
   PubMed Web of Science ®Google Scholar
• Kaur J, Kaur T, Sharma AK, et al. Fenofibrate attenuates ischemia reperfusion‐induced acute kidney injury and associated liver dysfunction in rats. Drug Dev Res. 2021;82(3):412–421. doi: 10.1002/ddr.21764.
   PubMed Web of Science ®Google Scholar
• Oidor-Chan VH, Hong E, Pérez-Severiano F, et al. Fenofibrate plus metformin produces cardioprotection in a type 2 diabetes and acute myocardial infarction model. PPAR Res. 2016;2016:8237264. doi: 10.1155/2016/8237264.
   PubMed Web of Science ®Google Scholar
• Yang FJ, He Y, Zhou J. Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury. J Huazhong Univ Sci Technolog Med Sci. 2015;35(1):58–63. doi: 10.1007/s11596-015-1389-2.
   PubMedGoogle Scholar
• Gelosa P, Banfi C, Gianella A, et al. Peroxisome proliferator-activated receptor α agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats. J Pharmacol Exp Ther. 2010;335(2):324–331. doi: 10.1124/jpet.110.171090.
   PubMed Web of Science ®Google Scholar